GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » 3-Year FCF Growth Rate

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) 3-Year FCF Growth Rate : -46.90% (As of Jun. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings 3-Year FCF Growth Rate?

Integrated Diagnostics Holdings's Free Cash Flow per Share for the three months ended in Jun. 2023 was $-0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -46.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 12 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Integrated Diagnostics Holdings was 116.50% per year. The lowest was -46.90% per year. And the median was -10.10% per year.


Competitive Comparison of Integrated Diagnostics Holdings's 3-Year FCF Growth Rate

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Diagnostics Holdings's 3-Year FCF Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's 3-Year FCF Growth Rate falls into.



Integrated Diagnostics Holdings 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Integrated Diagnostics Holdings  (OTCPK:IDGXF) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Integrated Diagnostics Holdings 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
12 Castle Street, Saint Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN 09-24-2021